Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function.

Treatment of chronic myelogenous leukemia (CML) with interferon-alpha frequently results in normalization of peripheral blood counts and, in up to 20% of patients, reestablishment of normal hematopoiesis. We hypothesize that interferon-alpha may restore normal adhesive interactions between CML proge...

Celý popis

Podrobná bibliografie

Vydáno v:	J Clin Invest
Hlavní autoři:	Bhatia, R, Wayner, E A, McGlave, P B, Verfaillie, C M
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Clinical Investigation 1994
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296320/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7518835/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI117333
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!